Crossref
Generalizability of Target Trial–Emulated Hemodiafiltration Evidence
Journal of the American Society of Nephrology · 10.11.2026
DOI: 10.1681/asn.0000001297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 10.11.2026. Verfasst von Daijun Hu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
clinical nephrologydialysis
Autor:innen und Institutionen
- Department of Nephrology, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China.
Zitieren
APA
Hu, D., & Tang, Y. (2026). Generalizability of Target Trial–Emulated Hemodiafiltration Evidence. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001297
Vancouver
Hu D, Tang Y. Generalizability of Target Trial–Emulated Hemodiafiltration Evidence. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001297
BibTeX
@article{Hu2026,
author = {Hu, Daijun and Tang, Yuewu},
title = {Generalizability of Target Trial–Emulated Hemodiafiltration Evidence},
journal = {Journal of the American Society of Nephrology},
year = {2026},
doi = {10.1681/asn.0000001297}
}
EUVIMED